Clinical Trial Update: All-trans Retinoic Acid, and Arsenic +/- Idarubicin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating all-trans retinoic acid with arsenic +/- idarubicin in acute promyelocytic leukemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Arsenic (Arsenic)
• Idarubicin (idarubicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Promyelocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-18